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Abstract: 
Background: Snake venoms contain various metalloproteinases that are highly toxic, inducing in 
severe bleeding by interfering with the blood coagulation and degrading the basement membrane or 
extracellular matrix (ECM) components. It has been suggested that hemorrhagic metalloproteinases 
interact in a specific way with platelet surface proteins resulting in an alteration of platelet function. 
Hemorrhage and tissue necrosis are common manifestations of viper envenomations in humans, 
largely due to the actions of prominent metalloproteinases. CcMP-II a weak hemorrhagic 
metalloproteinase purified from Cerastes cerastes venom belongs to the class P-II snake venom 
metalloproteinase.  
Methods: In this study, we characterized the biological effects of CcMP-II, including the ability of 
the enzyme to hydrolyze extracellular matrix components and plasma proteins, as well as its 
histopathological effects induced in capillaries. Then a study of the anti-aggregating activity was 
carried out and controlled for 10 min using our Chrono-log aggregometer (ServiBIO) (USTHB, 
Faculty of Biological Sciences, BP 32, El-Alia Bab Ezzouar, 16111, Algiers, Algeria in 2019). The 
histopathological changes induced by CcMP-II were also analyzed and the 1 µm semi-thin sections 
are then stained with Toluidine Blue and the observation of these sections was realized using a 
photomicroscope. Toluidine Blue, magnification: 100x. 
Results: Obtained results showed that CcMP-II metalloproteinase hydrolyzed selectively the A α-
chain of fibrinogen. This enzyme hydrolyzed also laminin and type IV collagen in time- and dose-
dependent manner. CcMP-II inhibits collagen-induced platelet aggregation of human PRP with an 
IC50 value of 0.11 nM.  Pathological changes induced by CcMP-II after intramuscular injection in 
mice gastrocnemius were also studied. Histological study showed that the main morphological 
alterations in capillary vessels are characterized by a separation of endothelial cells from the 
surrounding basement membrane and reduction in the width of these cells, together with loss of 
basement membrane in some areas, through which erythrocytes and plasma are extravasated. 
Conclusion: In conclusion, CcMP-II, as a member of the P-II class of SVMPs, presents a selective 
specificity toward fibrinogen, laminin and type IV collagen. It was an α- fibrinogenase 
metalloproteinase, which inhibits collagen-stimulated platelet aggregation. This study will 
contribute to understanding better the functional mechanisms of the metalloproteinases that may be 
useful in the development of therapeutic agents related to thrombotic disorders. 
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